Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qualia Iron is a multi-ingredient dietary supplement developed by Neurohacker Collective, specifically formulated to address iron deficiency and improve iron-related biomarkers. The product is designed to enhance iron absorption and utilization while minimizing common gastrointestinal side effects associated with traditional iron supplementation. It is currently being evaluated in a randomized, double-blind, placebo-controlled pilot study (NCT07156526) to assess its safety, efficacy, and impact on quality of life using a pulsed dosing schedule (5 days on, 2 days off). The formulation typically includes iron in a highly bioavailable form, such as iron bisglycinate, alongside synergistic co-factors intended to optimize iron metabolism and systemic health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qualia Iron.